Environmental enrichment slows disease progression in R6/2 Huntington's disease mice

Annals of Neurology

Volumn 51, Issue 2, 2002, Pages 235-242

  Hockly, Emma ^a,c   Cordery, Patricia M ^a   Woodman, Benjamin ^a   Mahal, Amarbirpal ^a   Van Dellen, Anton ^b   Blakemore, Colin ^a   Lewis, Cathryn M ^b   Hannan, Anthony J ^a   Bates, Gillian P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN SIZE; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; DISEASE MODEL; ENVIRONMENTAL FACTOR; FEMALE; GENE EXPRESSION REGULATION; GENETIC DISORDER; HUNTINGTON CHOREA; MOTOR DYSFUNCTION; MOUSE; NEUROLOGIC DISEASE; NEUROMODULATION; NONHUMAN; PERSONALITY DISORDER; PHENOTYPE; PREMATURITY; PRIORITY JOURNAL; TASK PERFORMANCE; TRANSGENIC ANIMAL;

ANIMALS; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; CORPUS STRIATUM; CYTOPLASMIC GRANULES; DISEASE PROGRESSION; ENVIRONMENT DESIGN; FEMALE; HAND STRENGTH; HUNTINGTON DISEASE; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; MOTOR ACTIVITY; PEPTIDES; PHENOTYPE; POLYMORPHISM, GENETIC; UBIQUITIN; WEIGHT LOSS;

EID: 0036152343     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10094     Document Type: Article

References (36)

1. Huntington's disease
2. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
3. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: Correlation between the density of inclusions and IT15 CAG triplet repeat length
4. Nuclear and neuropil aggregates in Huntington's Disease: Relationship to neuropathology
5. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
6. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation
7. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation
8. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
9. Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice
10. Delaying the onset of Huntington's in mice
11. Instability of highly expanded CAG repeats in mice transgenic for the Huntington's Disease mutation
12. PIC-betal, activated via MGIuRs, mediates activity-dependent differentiation in cerebral cortex
13. Effects of environmental enrichment on gene expression in the brain
14. Running enhances neurogenesis, learning, and long-term potentiation in mice
15. Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective
16. Environmental influence on behaviour and nerve growth factor in the brain
17. Neural consequences of environmental enrichment
18. Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene
19. Education and the prevalence of dementia and Alzheimer's disease
20. The prevalence of dementia and Alzheimer's Disease in Shanghai, China: Impact of age, gender, and education
21. Relationship of age, education, and occupation with dementia among a community-based sample of African Americans
22. Cognitive decline and education in mild dementia
23. Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons
24. Influence of education and occupation on the incidence of Alzheimer's disease
25. Physical activity and risk of cognitive impairment and dementia in elderly persons
26. Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members
27. Causes of Alzheimer's disease
28. Differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 after excitotoxicity in a rat model of Huntington's disease
29. Impaired proteasome function in Alzheimer's Disease
30. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins
31. Actions and interactions of the IGF system in Alzheimer's disease: Review and hypotheses
32. Apoptosis in neurodegenerative disorders
33. Monozygotic twins with Huntington's disease in a family expressing the rigid variant
34. Differential clinical and motor control function in a pair of monozygotic twins with Huntington's disease
35. Remotivation therapy and Huntington's disease